Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Medical - Devices

Healthcare
$1.20 -6.72%

-$0.09 today

Market cap
$50.65M
Beta
-1.23
P/E (TTM)
-1.3
EPS (TTM)
-$0.94
52W Low $0.76High $7.26

Volume 0.02M

Average 0.37M

BDMD Purchases of Investments

Cash used to buy marketable securities and other investments.

Baird Medical Investment Holdings LimitedNASDAQ: BDMD

Purchases of Investments · Q4 FY2025 · quarter ended Dec 2025

Purchases of investments outflow grows to $0

Q4 FY2025 purchases of investments was $0, compared with $0 a year earlier.

Context

  • Purchases of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Purchases of investments increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterDec 2025
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Purchases of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Purchases of Investments history

USD · from the cash flow

Latest · FY2025
0 USD
Year-over-year change
—

Purchases of Investments vs competitors

How BDMD compares with its peers on the latest reported figures

  • BDMD's FY2025 purchases of investments of $0 is the largest of the 4 companies compared; the peer median is $0.
  • Purchases of investments amounts to 0.0% of revenue for BDMD, versus a peer median of 0.0%.
BDMD Competitors Peer median
Purchases of Investments for BDMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BDMDBaird Medical Investment Holdings LimitedFY2025$0 ——0.0%
BDSXBiodesix, Inc.LTM Mar 2026$0 ——0.0%
ECORelectroCore, Inc.LTM Mar 2026$0 +100.0%—0.0%
OKUROnKure Therapeutics, Inc.LTM Mar 2026$0 -100.0%——
Peer median (excluding BDMD) $0+0.0%—0.0%

Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income10.18M12.77M10.55M12.6M(27.54M)
Depreciation & Amortization1.4M1.47M1.38M1.51M1.1M
Deferred Income Tax(45.38K)(143.32K)032.77K(53.5K)
Stock-Based Compensation000017.47M
Change in Working Capital(6.57M)(14.05M)(14.05M)(21.7M)6.79M
Accounts Receivables(3.49M)(14.1M)(9.67M)(17.8M)5.35M
Inventory(2.2M)1.57M113.66K(187.54K)260.28K
Accounts Payables274.31K(100.93K)0727.8K483.95K
Other Working Capital(1.15M)(1.41M)(4.49M)(4.44M)698.51K
Other Non-Cash Items286.05K433.58K1.11M1.25M884.64K
Operating Cash Flow5.26M485.97K(1.02M)(6.31M)(1.34M)
Capital Expenditures(1.39M)(5.95M)(2.64M)(2.85M)(42.32K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities561(12.16K)000
Investing Cash Flow(1.39M)(5.92M)(2.64M)(2.85M)(42.32K)
Debt Repayment(88.58K)4.46M2.35M10.31M(2.16M)
Common Stock Issued0002.9M0
Common Stock Repurchased00000
Dividends Paid(5.43M)0000
Other Financing Activities3.59M(46.4K)1.11M(2.49M)763.62K
Financing Cash Flow(1.93M)4.41M3.46M10.72M(1.39M)
Effect of Forex Changes0(297.65K)(3.11K)(94.27K)375.79K
Net Change in Cash1.96M(1.32M)(200.44K)1.46M(2.4M)
Free Cash Flow3.87M(5.47M)(3.66M)(9.17M)(1.39M)

Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Intrinsic Alpha fair value

Locked

Current Price

$1.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.